CRUM2_HUMAN - dbPTM
CRUM2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CRUM2_HUMAN
UniProt AC Q5IJ48
Protein Name Protein crumbs homolog 2 {ECO:0000305}
Gene Name CRB2 {ECO:0000312|HGNC:HGNC:18688}
Organism Homo sapiens (Human).
Sequence Length 1285
Subcellular Localization Isoform 1: Apical cell membrane
Single-pass type I membrane protein . O-glucosylation is required for localization at the apical plasma membrane.
Isoform 2: Secreted .
Protein Description Apical polarity protein that plays a central role during the epithelial-to-mesenchymal transition (EMT) at gastrulation, when newly specified mesodermal cells move inside the embryo. Acts by promoting cell ingression, the process by which cells leave the epithelial epiblast and move inside the embryo to form a new tissue layer. The anisotropic distribution of CRB2 and MYH10/myosin-IIB at cell edges define which cells will ingress: cells with high apical CRB2 are probably extruded from the epiblast by neighboring cells with high levels of apical MYH10/myosin-IIB. Also required for maintenance of the apical polarity complex during development of the cortex..
Protein Sequence MALARPGTPDPQALASVLLLLLWAPALSLLAGTVPSEPPSACASDPCAPGTECQATESGGYTCGPMEPRGCATQPCHHGALCVPQGPDPTGFRCYCVPGFQGPRCELDIDECASRPCHHGATCRNLADRYECHCPLGYAGVTCEMEVDECASAPCLHGGSCLDGVGSFRCVCAPGYGGTRCQLDLDECQSQPCAHGGTCHDLVNGFRCDCAGTGYEGTHCEREVLECASAPCEHNASCLEGLGSFRCLCWPGYSGELCEVDEDECASSPCQHGGRCLQRSDPALYGGVQAAFPGAFSFRHAAGFLCHCPPGFEGADCGVEVDECASRPCLNGGHCQDLPNGFQCHCPDGYAGPTCEEDVDECLSDPCLHGGTCSDTVAGYICRCPETWGGRDCSVQLTGCQGHTCPLAATCIPIFESGVHSYVCHCPPGTHGPFCGQNTTFSVMAGSPIQASVPAGGPLGLALRFRTTLPAGTLATRNDTKESLELALVAATLQATLWSYSTTVLVLRLPDLALNDGHWHQVEVVLHLATLELRLWHEGCPARLCVASGPVALASTASATPLPAGISSAQLGDATFAGCLQDVRVDGHLLLPEDLGENVLLGCERREQCRPLPCVHGGSCVDLWTHFRCDCARPHRGPTCADEIPAATFGLGGAPSSASFLLQELPGPNLTVSFLLRTRESAGLLLQFANDSAAGLTVFLSEGRIRAEVPGSPAVVLPGRWDDGLRHLVMLSFGPDQLQDLGQHVHVGGRLLAADSQPWGGPFRGCLQDLRLDGCHLPFFPLPLDNSSQPSELGGRQSWNLTAGCVSEDMCSPDPCFNGGTCLVTWNDFHCTCPANFTGPTCAQQLWCPGQPCLPPATCEEVPDGFVCVAEATFREGPPAAFSGHNASSGRLLGGLSLAFRTRDSEAWLLRAAAGALEGVWLAVRNGSLAGGVRGGHGLPGAVLPIPGPRVADGAWHRVRLAMERPAATTSRWLLWLDGAATPVALRGLASDLGFLQGPGAVRILLAENFTGCLGRVALGGLPLPLARPRPGAAPGAREHFASWPGTPAPILGCRGAPVCAPSPCLHDGACRDLFDAFACACGPGWEGPRCEAHVDPCHSAPCARGRCHTHPDGRFECRCPPGFGGPRCRLPVPSKECSLNVTCLDGSPCEGGSPAANCSCLEGLAGQRCQVPTLPCEANPCLNGGTCRAAGGVSECICNARFSGQFCEVAKGLPLPLPFPLLEVAVPAACACLLLLLLGLLSGILAARKRRQSEGTYSPSQQEVAGARLEMDSVLKVPPEERLI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
235N-linked_GlycosylationASAPCEHNASCLEGL
HCCCCCCCCHHHHCC
15.97UniProtKB CARBOHYD
244PhosphorylationSCLEGLGSFRCLCWP
HHHHCCCCEEEEECC
17.9824719451
267O-linked_GlycosylationVDEDECASSPCQHGG
ECCHHHCCCCCCCCC
46.61-
297PhosphorylationAAFPGAFSFRHAAGF
CCCCCCEEHHHCCCE
22.3424719451
438N-linked_GlycosylationHGPFCGQNTTFSVMA
CCCCCCCCCEEEEEC
26.77UniProtKB CARBOHYD
476PhosphorylationLPAGTLATRNDTKES
CCCCCEECCCCHHHH
32.87-
478N-linked_GlycosylationAGTLATRNDTKESLE
CCCEECCCCHHHHHH
57.88UniProtKB CARBOHYD
480PhosphorylationTLATRNDTKESLELA
CEECCCCHHHHHHHH
40.02-
560O-linked_GlycosylationLASTASATPLPAGIS
EEECCCCCCCCCCCC
23.90OGP
669N-linked_GlycosylationLQELPGPNLTVSFLL
HHHCCCCCEEEEEEE
55.01UniProtKB CARBOHYD
673PhosphorylationPGPNLTVSFLLRTRE
CCCCEEEEEEEECHH
12.6324719451
690N-linked_GlycosylationGLLLQFANDSAAGLT
CCEEEECCCCCCCEE
45.09UniProtKB CARBOHYD
786N-linked_GlycosylationFFPLPLDNSSQPSEL
CCCCCCCCCCCCHHH
51.77UniProtKB CARBOHYD
800N-linked_GlycosylationLGGRQSWNLTAGCVS
HCCCCCEECCCCCCC
32.53UniProtKB CARBOHYD
836N-linked_GlycosylationFHCTCPANFTGPTCA
EEEECCCCCCCCCCH
21.83UniProtKB CARBOHYD
886N-linked_GlycosylationPAAFSGHNASSGRLL
CCCCCCCCCCCCCCC
45.07UniProtKB CARBOHYD
926N-linked_GlycosylationGVWLAVRNGSLAGGV
CEEEEEECCCCCCCC
37.49UniProtKB CARBOHYD
970PhosphorylationMERPAATTSRWLLWL
HCCCCCCCCCCHHHH
16.15-
971PhosphorylationERPAATTSRWLLWLD
CCCCCCCCCCHHHHC
19.66-
1009N-linked_GlycosylationVRILLAENFTGCLGR
HHEEEECCCCCCCHH
33.89UniProtKB CARBOHYD
1141N-linked_GlycosylationPSKECSLNVTCLDGS
CCCCEEEEEEEECCC
15.68UniProtKB CARBOHYD
1158N-linked_GlycosylationEGGSPAANCSCLEGL
CCCCCCCCCCCCCCC
21.97UniProtKB CARBOHYD
1261PhosphorylationSEGTYSPSQQEVAGA
CCCCCCHHHHHHCCC
38.2628857561
1274PhosphorylationGARLEMDSVLKVPPE
CCEEECCCCCCCCHH
28.2119664994

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CRUM2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CRUM2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CRUM2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
616220Focal segmental glomerulosclerosis 9 (FSGS9)
219730Ventriculomegaly with cystic kidney disease (VMCKD)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CRUM2_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP